DAMONA Pharmaceuticals was recently highlighted in a news article, prepared by Ben Gane, for the University of Toronto. This article highlights the creation of Damona by CAMH (the Centre of Addiction and Mental Health in Toronto) and Dr. Etienne Sibille. Full Article In this article, you can learn about the company’s achievements that have attracted…
read moreDAMONA raises US5.5 Million Seed Stage Financing to Advance Lead Molecule Development to Treat Cognitive Deficits
read moreWe are delighted to announce that the Ontario Brain Institute (OBI) is investing approximately $400,000 CAD in Damona Pharmaceuticals, to provide support to the company developing treatments for cognitive deficits in depression and other brain disorders. DAMONA’s team is excited to engage with OBI, and thank them for their support.
read moreWhat could prevent suicide? For CAMH and mental health advocates, it’s advances in research and treatment. Article on TORONTO STAR What could prevent suicide? For CAMH and mental health advocates, it’s advances in research and treatment. For decades, suicide and mental health were taboo topics in most social circles. Opening upabout personal struggles was often…
read moreFind out more about Dr. Sibille’s research at camh, and how it relates to Research & Development in AlphaCog. Link to Camh Website Long before the technology existed that allows CAMH scientists to observe what is actually going on in the living brain, none other than Dr. Sigmund Freud declared that the brains of people…
read more